Acura's Meth-Impeding Nexafed Pseudoephedrine Could Transform Category

Acura Pharmaceuticals hopes its "extraction-resistant" pseudoephedrine hydrochloride tablet can break free of the pharmacy counter to true OTC status, and help protect the popular decongestant ingredient from becoming prescription-only, a top executive said.

More from Archive

More from Pink Sheet